Working... Menu
Trial record 1 of 1 for:    Pazopanib or Pemetrexed and Crizotinib
Previous Study | Return to List | Next Study

Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01548144
Recruitment Status : Active, not recruiting
First Posted : March 8, 2012
Last Update Posted : June 6, 2019
Information provided by (Responsible Party):
M.D. Anderson Cancer Center